Khan, M. S. S. (2017). The Development Of Rosmarinic Acid Derivatives To Target Il17a In Glioblastoma Multiforme Via Angiogenic Pathways.
Chicago Style (17th ed.) CitationKhan, Md Shamsuddin Sultan. The Development Of Rosmarinic Acid Derivatives To Target Il17a In Glioblastoma Multiforme Via Angiogenic Pathways. 2017.
MLA (9th ed.) CitationKhan, Md Shamsuddin Sultan. The Development Of Rosmarinic Acid Derivatives To Target Il17a In Glioblastoma Multiforme Via Angiogenic Pathways. 2017.
Warning: These citations may not always be 100% accurate.